Faceland vacancies
About Faceland
Faceland was founded in 2013 with a clear ambition: to make cosmetic medicine accessible to a much wider audience. The organisation has since grown to become the Dutch market leader, with more than thirty clinics spread across the country. Faceland is also active in Belgium, Germany and Switzerland. Since private equity investor Verlinvest acquired a majority stake in 2023, Faceland has had the clout to scale up internationally without compromising on quality and professionalism. The combination of medical expertise, scale and transparency forms the basis for further growth.
The mission
Faceland offers a wide range of cosmetic and medical treatments, from injectables such as Botox and fillers to more invasive procedures, including eyelid corrections. All treatments are performed by qualified medical professionals trained at Faceland’s own academy. The mission is clear: to make clients happy with more than they expect, for less than they think. At the same time, the founders are actively committed to increasing professionalism within the industry, including through training and medical research. In this way, Faceland not only wants to grow in size, but also contribute to the further development of the field.
European market leadership
With market leadership in the Netherlands as its starting point, Faceland is now focusing on Europe. They have the momentum on their side: cosmetic treatments are becoming increasingly mainstream and free of taboos. A pleasant trend to ride. The ambitions are considerable: the company wants to open around fifteen new locations every year. Germany is considered the most important growth market, but the company is also rapidly expanding its presence in the Netherlands, Belgium, Switzerland and other European countries. With the support of Verlinvest, Faceland is building a scalable and professional platform that is ready for long-term growth in multiple countries.
Netherlands
Germany
Spain